연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Si Eun Kim has not added Biography.
If you are Si Eun Kim and would like to personalize this page please email our Author Liaison for assistance.
Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis.
PloS one , 2009 | Pubmed ID: 19584937
Isolated foot drop in acute infarction of the supplementary motor area.
Clinical neurology and neurosurgery Oct, 2013 | Pubmed ID: 23911001
An elderly case of acute cerebellitis after alleged vaccination.
Journal of movement disorders May, 2012 | Pubmed ID: 24868409
Surface Modification of Melt Extruded Poly(ε-caprolactone) Nanofibers: Toward a New Scalable Biomaterial Scaffold.
ACS macro letters Jun, 2014 | Pubmed ID: 24977107
Response to antiepileptic drugs in partial epilepsy with structural lesions on MRI.
Clinical neurology and neurosurgery Aug, 2014 | Pubmed ID: 25012014
Comparison of phytoncide with sirolimus as a novel drug candidate for drug-eluting stent.
Biomaterials Mar, 2015 | Pubmed ID: 25617121
Can the adverse effects of antiepileptic drugs be detected in saccadic eye movements?
Seizure Feb, 2015 | Pubmed ID: 25645633
Coextruded, aligned, and gradient-modified poly(ε-caprolactone) fibers as platforms for neural growth.
Biomacromolecules Mar, 2015 | Pubmed ID: 25715836
ABION CRO
Nirmal Rajasekaran1,
Myung Ryurl Oh3,
Sung-Su Kim1,
Si Eun Kim3,
Young Deug Kim4,
Hyun-Jeung Choi2,
Bohyun Byun2,
Young Kee Shin1,2
1Research Institute of Pharmaceutical Science, Department of Pharmacy, College of Pharmacy, Seoul National University,
2The Center for Anti-Cancer CDx, N-Bio, Seoul National University,
3, ABION CRO,
4, ABION Inc., R&D Center
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유